People with type 2 diabetes should contact their physicians if symptoms of heart failure appear.
Diabetes Drug News
Diabetes Drugs are responsible for helping to decrease blood sugar levels so that you can try to stay in a healthier range and help avoid serious complications.
Metformin Insulin SGLT-2 GLP-1 DPP-4 Combo drugs Sulfonylureas TZDs
27 readers recommended
The Annual TCOYD/The diaTribe Foundation Forum Celebrates its 10 th Anniversary in New Orleans
29 readers recommended
Making major improvements over current standard of care – how does this new treatment work? The FDA recently approved a new indication for a product that has been used...
35 readers recommended
Plus, what people with diabetes and healthcare providers can do
33 readers recommended
JDRF and Helmsley Charitable Trust workshop highlights future goals and expectations for glucose-responsive insulin.
33 readers recommended
College Diabetes Network’s free “Off to College” booklets on overcoming diabetes challenges during the college transition
38 readers recommended
People with type 2 diabetes should contact their physicians if they notice new pain, sores, or infections on their legs or feet.
46 readers recommended
Results from the SCALE study show weight loss, delayed onset of type 2 diabetes, and report improved quality of life
45 readers recommended
Matchstick-sized device implanted under the skin every 6-12 months. New data in over 4,000 people demonstrates it is safe for heart health. Could it launch by late 2017?
24 readers recommended
Patients with high A1c levels could achieve greater blood glucose control from the start.
21 readers recommended
A six-month study of Diasome Pharmaceuticals’ HDV Insulin in Type 1 Diabetes
33 readers recommended
Public workshop scheduled at FDA for August 29, 2016. Get involved!
28 readers recommended
Use 4 mm needles, rotate injection sites, and more – why the little stuff matters
37 readers recommended
What are the implications for other injected GLP-1 agonist drugs?
37 readers recommended
MannKind has re-launched the inhaled mealtime insulin, Afrezza, alongside new initiatives to promote the product
38 readers recommended
A currently-enrolling trial is investigating a new arthritis medication along with type 2 diabetes drug Victoza, aiming to preserve insulin production in people with...
57 readers recommended
Despite neutral heart outcome study results, the FDA added a warning for those at risk of heart failure
34 readers recommended
By Maeve Serino and Adam Brown Learn about what’s new and what’s coming soon in Smart Pens, automated insulin delivery, pumps, and more Diabetes technology moves fast,...
44 readers recommended
A decision on Novo Nordisk’s faster-acting mealtime insulin is expected in late 2017; also launched in Canada, Germany, and the UK, and coming soon to more European...
42 readers recommended
Sanofi’s insulin adjustment app to help people with type 2 diabetes optimize once-daily long-acting basal insulin is now available for Apple and Android devices